This whale alert can help traders discover the next big trading opportunities. Whales are entities w

JNJ's growth gets a boost from new drug launches and pipeline wins, but Stelara's patent loss and Me

Younger investors are rewriting the rules of wealth building, and five overlooked dividend stocks un

Dividend Kings have a 50+ year track record of increasing dividends, showcasing resilience through e

Building a $100,000 dividend snowball is foundational for financial security and passive income. I d

Nykredit A S bought a new position in shares of Johnson and Johnson (NYSE: JNJ) in the second quarte

Smith Chas P and Associates PA Cpas decreased its stake in shares of Johnson and Johnson (NYSE: JNJ)

Johnson & Johnson has raised its dividend for 64 straight years, but faces billions in talc-related

In the most recent trading session, Johnson & Johnson (JNJ) closed at $270.22, indicating a +1.1% sh

Johnson & Johnson (JNJ) Presents at Deutsche Bank 2026 Healthcare Summit Transcript

Retirees chasing a simple $500 monthly check from VYM run straight into a gap between how yields are

Johnson & Johnson NYSE: JNJ Executive Vice President and Chief Financial Officer Joe Wolk said the c

Fed uncertainty, oil prices, and macro pressures are bringing inflation and interest-rate fears to a

U S Wealth Group LLC. raised its stake in Johnson and Johnson (NYSE: JNJ) by 15.1% in the undefined

Talon Private Wealth LLC grew its holdings in shares of Johnson and Johnson (NYSE: JNJ) by 89.5% in

The Manufacturers Life Insurance Company lifted its stake in shares of Johnson and Johnson (NYSE: JN

Van Hulzen Asset Management LLC reduced its stake in shares of Johnson and Johnson (NYSE: JNJ) by 4.

National Pension Service grew its holdings in Johnson and Johnson (NYSE: JNJ) by 1.3% during the sec

Blue Edge Capital LLC reduced its stake in Johnson and Johnson (NYSE: JNJ) by 18.7% in the undefined

Core Capital Management and Research inc. bought a new position in Johnson and Johnson (NYSE: JNJ) d

Johnson and Johnson (JNJ), the pharmaceutical and medical-technology giant, added another potentiall

Realty Income pays you every month while Johnson and Johnson barely clears 2% yield, yet one of thes

It is certainly a good Dividend King to buy in September.

The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should tak

These players offer a certain level of stability in any market environment.

HighTower Advisors LLC decreased its stake in shares of Johnson and Johnson (NYSE: JNJ) by 5.6% duri

IFP Advisors Inc raised its stake in Johnson and Johnson (NYSE: JNJ) by 8.8% during the second quart

Corient Private Wealth LP lowered its position in Johnson and Johnson (NYSE: JNJ) by 14.7% in the se

Waverly Advisors LLC grew its stake in shares of Johnson and Johnson (NYSE: JNJ) by 15.6% in the und

Empirical Finance LLC boosted its stake in shares of Johnson and Johnson (NYSE: JNJ) by 3.4% in the

Tucker Asset Management LLC raised its position in shares of Johnson and Johnson (NYSE: JNJ) by 173.

HORAN Wealth LLC trimmed its position in shares of Johnson and Johnson (NYSE: JNJ) by 51.5% in the s

A U.S. senator has added small cap stock ETFs to his portfolio ahead of a potential Federal Reserve

When it comes to investing, there is no one-size-fits-all approach. Strategies vary based on numerou

Johnson & Johnson released positive Phase 2b and Phase 3 trial results for its Rybrevant lung ca

Contineum Therapeutics, Inc. (NASDAQ:CTNM) shares are trading lower on Tuesday as Phase 2 results fr

Contineum Therapeutics shares fall as Phase 2 MOONLIGHT-1 depression trial fails primary endpoint. P

Recently, Zacks.com users have been paying close attention to Johnson & Johnson (JNJ). This makes it

Retirees don't need the highest yield on the board. They need the check to keep arriving, and to kee

California State Teachers Retirement System grew its position in Johnson and Johnson (NYSE: JNJ) by

Tobias Financial Advisors Inc. cut its holdings in shares of Johnson and Johnson (NYSE: JNJ) by 48.0

Saudi Central Bank lifted its position in shares of Johnson and Johnson (NYSE: JNJ) by 35.7% during

HB Wealth Management LLC cut its stake in shares of Johnson and Johnson (NYSE: JNJ) by 0.8% in the u

Kintra Wealth LLC raised its holdings in Johnson and Johnson (NYSE: JNJ) by 7.8% in the undefined qu

VIRGINIA RETIREMENT SYSTEMS ET Al purchased a new position in shares of Johnson and Johnson (NYSE: J

Low rates of rash, blood clots and administration-related reactions were observed with subcutaneous

Low rates of rash, blood clots and administration-related reactions were observed with subcutaneous

Contineum Therapeutics said on Monday an experimental depression drug it developed with Johnson & ​J

Phase 2 MOONLIGHT-1 trial did not meet its primary efficacy endpointAnalyses of the data, including

SAN DIEGO--(BUSINESS WIRE)--Contineum Therapeutics, Inc. (NASDAQ: CTNM) (Contineum or the Company),